# A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)

> **NCT00758836** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 683 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** placebo
- **DRUG:** ibuprofen
- **DRUG:** acetominophen
- **DRUG:** telcagepant

## Key facts

- **NCT ID:** NCT00758836
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12-03
- **Primary completion:** 2009-08-24
- **Final completion:** 2009-08-24
- **Target enrollment:** 683 (ACTUAL)
- **Last updated:** 2018-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00758836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00758836, "A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00758836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*